Cengild Medical Berhad (0243) - Total Liabilities
Based on the latest financial reports, Cengild Medical Berhad (0243) has total liabilities worth RM101.09 Million MYR (≈ $25.38 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Cengild Medical Berhad net asset momentum to track the company's year-over-year net asset growth rate.
Cengild Medical Berhad - Total Liabilities Trend (2020–2025)
This chart illustrates how Cengild Medical Berhad's total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of Cengild Medical Berhad to measure how efficiently the company converts operating cash flow to free cash.
Cengild Medical Berhad Competitors by Total Liabilities
The table below lists competitors of Cengild Medical Berhad ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ta Jiang Co Ltd
TW:1453
|
Taiwan | NT$1.58 Billion |
|
Namhwa Industrial Co. Ltd
KQ:111710
|
Korea | ₩13.10 Billion |
|
Hung Chou Fiber Ind Co Ltd
TW:1413
|
Taiwan | NT$1.50 Billion |
|
Environmental Clean Technologies Ltd
AU:ECT
|
Australia | AU$1.46 Million |
|
GeneFerm Biotechnology Co Ltd
TWO:1796
|
Taiwan | NT$453.10 Million |
|
Lake Victoria Gold Ltd.
V:LVG
|
Canada | CA$1.93 Million |
|
Bowim S.A.
WAR:BOW
|
Poland | zł260.95 Million |
Liability Composition Analysis (2020–2025)
This chart breaks down Cengild Medical Berhad's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Cengild Medical Berhad (0243) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.90 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.86 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.46 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Cengild Medical Berhad's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Cengild Medical Berhad (2020–2025)
The table below shows the annual total liabilities of Cengild Medical Berhad from 2020 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | RM66.03 Million ≈ $16.58 Million |
+212.27% |
| 2024-06-30 | RM21.15 Million ≈ $5.31 Million |
-17.46% |
| 2023-06-30 | RM25.62 Million ≈ $6.43 Million |
-3.66% |
| 2022-06-30 | RM26.59 Million ≈ $6.68 Million |
-17.41% |
| 2021-06-30 | RM32.20 Million ≈ $8.08 Million |
-13.68% |
| 2020-06-30 | RM37.30 Million ≈ $9.37 Million |
-- |
About Cengild Medical Berhad
Cengild Medical Berhad, an investment holding company, operates a medical center in Malaysia. The company offers various care and treatment consultant services for gastrointestinal and liver diseases, morbid obesity, and oncology and urological conditions; general cardiology and gynecology assessment; gastroenterology and hepatology; anesthesiology, general surgery, internal medicine, and radiolo… Read more